Gedatolisib (PF-05212384, PKI-587) is a highly effective dual inhibitor of PI3K alpha, PI3K gamma, and mTOR, with IC50 values of 0.4 nM, 5.4 nM, and 1.6 nM in cell-free assays, respectively.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.